Exness_Official

XPeng negative picture could still be attractive to investors

NYSE:XPEV   XPeng Inc.
XPeng Inc. (symbol ‘XPEV’) share price has been trading in a slight bearish momentum for the last 3 months without any signs of bullish reversal. The company’s earnings report for the fiscal quarter ending December 2022 is set to be released on Friday 17th of March, before market open. The consensus EPS for Q4 is $-0,05 compared to Q4 2022’s $-0,24.

‘The share is trading at its all time low since the day of joining the New York Stock Exchange in September of 2020 after losing more than 80% of its valuation in 2022. The profit and loss statement is not looking good with the company recording net losses for the last 4 years and resulting in negative P/E and PEG ratios. The company’s share is undervalued by more than 45% which despite the negative financials it might still be considered an attractive investment option for long term investors since it has the potential to grow and possibly reach its all time high of more than $70 in 2020.’ said Antreas Themistokleous at Exness. ‘Xpeng (XPEV) will join the Hang Seng TECH Index, according to the company on March 7. The company is also expected to join the Hang Seng China Enterprises Index by mid-month, replacing China Feihe.’

From the technical analysis perspective the price has been trading in a declining trading channel in the last 3 months and is currently between the 50 and 100 moving averages , also known as “dynamic area”. The $10 area is a strong resistance since it consists of the 50% of the Fibonacci , the 50 day moving average and also the psychological resistance of the round number.

A continuation to the downside could find some support around $$8,90 which is the 61.8% of the Fibonacci and also an inside support area since late January.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.